The second person ever has received a transplant with a genetically modified pig kidney.
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as part of a new clinical trial sanctioned by the Food and Drug Administration.
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...
A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time ...
Scientists are genetically altering pigs so their organs are more humanlike to address the transplant shortage. More than 100 ...
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results